help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turgeon, J. L.
Right arrow Articles by Waring, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turgeon, J. L.
Right arrow Articles by Waring, D. W.

Molecular Endocrinology, Vol 8, 860-869, Copyright © 1994 by Endocrine Society

ARTICLES

Activation of the progesterone receptor by the gonadotropin-releasing hormone self-priming signaling pathway

JL Turgeon and DW Waring
Department of Human Physiology School of Medicine University of California, Davis 95616.

Signal amplification is fundamental to the normal operation of the preovulatory LH surge and is achieved through processes such as GnRH self-priming and augmentation of stimulated LH secretion by progesterone. We have proposed a model for GnRH self-priming that requires cross-communication between a GnRH receptor-activated protein kinase A pathway and the progesterone receptor (PR) to achieve amplification of the GnRH signal. We found that a pulse of GnRH administered to gonadotrope-enriched pituitary cells cultured in medium containing charcoal-treated serum plus estradiol (E2) potentiated the LH secretory response to subsequent GnRH pulses, and this potentiation could be blocked by a PR antagonist, RU486, in the absence of progesterone. Similarly, exposure of gonadotrope-enriched cultures to forskolin augmented the response to a pulse of GnRH, and the augmentation due to cAMP elevation could be reduced by RU486 in the absence of progesterone. To directly test whether stimulation with either GnRH or a cAMP analog results in transactivation of the endogenous PR, we used rat anterior pituitary cells cultured in the presence of E2 and transfected with reporter plasmids containing progesterone-responsive elements (PRE) and either a E1b or a thymidine kinase (tk) promoter linked to the chloramphenicol acetyltransferase (CAT) gene. For pituitary cells transfected with the PRE-E1b-CAT plasmid, exposure to either progesterone, GnRH, or 8-bromo-cAMP (8BrcAMP) for 6 h resulted in an induction of CAT activity which could be suppressed by coincubation with RU486. RU486 by itself had no effect on CAT activity. Similar results were obtained when a plasmid containing a different promoter (PRE-tk-CAT) was used. For cells transfected with a construct lacking a PRE (pSV2CAT), 8BrcAMP was without effect on CAT expression. When cells were made PR-deficient by omission of E2 from the incubation medium and transfected with PRE-E1b- CAT, neither progesterone, GnRH, nor 8BrcAMP was able to induce CAT activity. In summary we found that either GnRH or 8BrcAMP is able to stimulate transcription of reporter genes linked to two different PRE- containing promoters in anterior pituitary cells that contain endogenous PR; this occurred in the absence of progesterone and was suppressed by a PR antagonist. A simple interpretation of these data is that a GnRH-triggered signaling cascade can result in progesterone- independent transactivation of the PR. We propose that, in the normal operation of the preovulatory LH surge, the pathways for GnRH self- priming and progesterone augmentation converge at the PR and that the pathways serve as physiological redundancies to ensure the LH surge.


This article has been cited by other articles:


Home page
 EndocrinologyHome page
S. Mani
Progestin Receptor Subtypes in the Brain: The Known and the Unknown
Endocrinology, June 1, 2008; 149(6): 2750 - 2756.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
A. Gordon, J. C Garrido-Gracia, R. Aguilar, C. Bellido, J. A G. Velasco, Y. Millan, M. Tena-Sempere, J. Martin de las Mulas, and J. E Sanchez-Criado
The ovary-mediated FSH attenuation of the LH surge in the rat involves a decreased gonadotroph progesterone receptor (PR) action but not PR expression
J. Endocrinol., March 1, 2008; 196(3): 583 - 592.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. Kowase, H. E. Walsh, D. S. Darling, and M. A. Shupnik
Estrogen Enhances Gonadotropin-Releasing Hormone-Stimulated Transcription of the Luteinizing Hormone Subunit Promoters via Altered Expression of Stimulatory and Suppressive Transcription Factors
Endocrinology, December 1, 2007; 148(12): 6083 - 6091.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
J. C Garrido-Gracia, A. Gordon, C. Bellido, R. Aguilar, I. Barranco, Y. Millan, J. M. de las Mulas, and J. E Sanchez-Criado
The integrated action of oestrogen receptor isoforms and sites with progesterone receptor in the gonadotrope modulates LH secretion: evidence from tamoxifen-treated ovariectomized rats
J. Endocrinol., April 1, 2007; 193(1): 107 - 119.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
J. L Turgeon and D. W Waring
Differential expression and regulation of progesterone receptor isoforms in rat and mouse pituitary cells and L{beta}T2 gonadotropes.
J. Endocrinol., September 1, 2006; 190(3): 837 - 846.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B.-S. An, D. M. Selva, G. L. Hammond, A. Rivero-Muller, N. Rahman, and P. C. K. Leung
Steroid Receptor Coactivator-3 Is Required for Progesterone Receptor Trans-activation of Target Genes in Response to Gonadotropin-releasing Hormone Treatment of Pituitary Cells
J. Biol. Chem., July 28, 2006; 281(30): 20817 - 20824.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
J. E Sanchez-Criado, J. C Garrido-Gracia, C. Bellido, R. Aguilar, P. Guelmes, P. Abreu, R. Alonso, I. Barranco, Y. Millan, and J. M. de las Mulas
Oestradiol-17{beta} inhibits tamoxifen-induced LHRH self-priming blocking hormone-dependent and ligand-independent activation of the gonadotrope progesterone receptor in the rat.
J. Endocrinol., July 1, 2006; 190(1): 73 - 84.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
R Aguilar, C Bellido, J C Garrido-Gracia, R Alonso, and J E Sanchez-Criado
Estradiol and its membrane-impermeable conjugate estradiol-BSA inhibit tamoxifen-stimulated prolactin secretion in incubated rat pituitaries.
Reproduction, April 1, 2006; 131(4): 763 - 769.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. M. Olesen, H. M. Jessen, C. J. Auger, and A. P. Auger
Dopaminergic Activation of Estrogen Receptors in Neonatal Brain Alters Progestin Receptor Expression and Juvenile Social Play Behavior
Endocrinology, September 1, 2005; 146(9): 3705 - 3712.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
J. E Sanchez-Criado, C. Bellido, R. Aguilar, and J. C Garrido-Gracia
A paradoxical inhibitory effect of oestradiol-17{beta} on GnRH self-priming in pituitaries from tamoxifen-treated rats
J. Endocrinol., July 1, 2005; 186(1): 43 - 49.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. W. Hill, J. H. Urban, M. Xu, and J. E. Levine
Estrogen Induces Neuropeptide Y (NPY) Y1 Receptor Gene Expression and Responsiveness to NPY in Gonadotrope-Enriched Pituitary Cell Cultures
Endocrinology, May 1, 2004; 145(5): 2283 - 2290.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. C. Rigas, D. M. Ozanne, D. E. Neal, and C. N. Robson
The Scaffolding Protein RACK1 Interacts with Androgen Receptor and Promotes Cross-talk through a Protein Kinase C Signaling Pathway
J. Biol. Chem., November 14, 2003; 278(46): 46087 - 46093.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Ueda, N. R. Mawji, N. Bruchovsky, and M. D. Sadar
Ligand-independent Activation of the Androgen Receptor by Interleukin-6 and the Role of Steroid Receptor Coactivator-1 in Prostate Cancer Cells
J. Biol. Chem., October 4, 2002; 277(41): 38087 - 38094.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. L. Turgeon, G. Shyamala, and D. W. Waring
PR Localization and Anterior Pituitary Cell Populations in Vitro in Ovariectomized Wild-Type and PR-Knockout Mice
Endocrinology, October 1, 2001; 142(10): 4479 - 4485.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. Demay, M. De Monti, C. Tiffoche, C. Vaillant, and M. L. Thieulant
Steroid-Independent Activation of ER by GnRH in Gonadotrope Pituitary Cells
Endocrinology, August 1, 2001; 142(8): 3340 - 3347.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. L. Turgeon and D. W. Waring
Luteinizing Hormone Secretion from Wild-Type and Progesterone Receptor Knockout Mouse Anterior Pituitary Cells
Endocrinology, July 1, 2001; 142(7): 3108 - 3115.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. D. Sadar and M. E. Gleave
Ligand-independent Activation of the Androgen Receptor by the Differentiation Agent Butyrate in Human Prostate Cancer Cells
Cancer Res., October 1, 2000; 60(20): 5825 - 5831.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
M. Xu, J. H. Urban, J. W. Hill, and J. E. Levine
Regulation of Hypothalamic Neuropeptide Y Y1 Receptor Gene Expression during the Estrous Cycle: Role of Progesterone Receptors
Endocrinology, September 1, 2000; 141(9): 3319 - 3327.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. L. Turgeon and D. W. Waring
Progesterone Regulation of the Progesterone Receptor in Rat Gonadotropes
Endocrinology, September 1, 2000; 141(9): 3422 - 3429.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P. E. Chappell and J. E. Levine
Stimulation of Gonadotropin-Releasing Hormone Surges by Estrogen. I. Role of Hypothalamic Progesterone Receptors
Endocrinology, April 1, 2000; 141(4): 1477 - 1485.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P. E. Chappell, J. Lee, and J. E. Levine
Stimulation of Gonadotropin-Releasing Hormone Surges by Estrogen. II. Role of Cyclic Adenosine 3',5'-Monophosphate
Endocrinology, April 1, 2000; 141(4): 1486 - 1492.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P. E. Chappell, J. S. Schneider, P. Kim, M. Xu, J. P. Lydon, B. W. O’Malley, and J. E. Levine
Absence of Gonadotropin Surges and Gonadotropin-Releasing Hormone Self-Priming in Ovariectomized (OVX), Estrogen (E2)-Treated, Progesterone Receptor Knockout (PRKO) Mice
Endocrinology, August 1, 1999; 140(8): 3653 - 3658.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
J. L. Turgeon, S. M. Van Patten, G. Shyamala, and D. W. Waring
Steroid Regulation of Progesterone Receptor Expression in Cultured Rat Gonadotropes
Endocrinology, May 1, 1999; 140(5): 2318 - 2325.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
J. L. Turgeon and D. W. Waring
Androgen Modulation of Luteinizing Hormone Secretion by Female Rat Gonadotropes
Endocrinology, April 1, 1999; 140(4): 1767 - 1774.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
M. D. Sadar
Androgen-independent Induction of Prostate-specific Antigen Gene Expression via Cross-talk between the Androgen Receptor and Protein Kinase A Signal Transduction Pathways
J. Biol. Chem., March 19, 1999; 274(12): 7777 - 7783.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. J. Evans
Modulation of Gonadotropin Levels by Peptides Acting at the Anterior Pituitary Gland
Endocr. Rev., February 1, 1999; 20(1): 46 - 67.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
M. Szabo, S. M. Kilen, S. Saberi, S. J. Ringstrom, and N. B. Schwartz
Antiprogestins Suppress Basal and Activin-Stimulated Follicle-Stimulating Hormone Secretion in an Estrogen-Dependent Manner
Endocrinology, May 1, 1998; 139(5): 2223 - 2228.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P. E. Chappell, J. P. Lydon, O. M. Conneely, B. W. O' Malley, and J. E. Levine
Endocrine Defects in Mice Carrying a Null Mutation for the Progesterone Receptor Gene
Endocrinology, October 1, 1997; 138(10): 4147 - 4152.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
Y. Zhang, C. A. Beck, A. Poletti, J. P. Clement IV, P. Prendergast, T.-T. Yip, T. W. Hutchens, D. P. Edwards, and N. L. Weigel
Phosphorylation of Human Progesterone Receptor by Cyclin-Dependent Kinase 2 on Three Sites That Are Authentic Basal Phosphorylation Sites In Vivo
Mol. Endocrinol., June 1, 1997; 11(6): 823 - 832.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society